IMPERATIVE NEED TO IMPROVE OUTCOMES FOR WOMEN DIAGNOSED WITH OVARIAN CANCER. ANZGOG Chair gives stark assessment on late diagnosis, limited treatment options and significantly low survival rates
With
Professor Clare Scott, Chair
Australia New Zealand Gynaecological Oncology Group (ANZGOG) &
Clinician Scientist
WEHI The Walter and Eliza Hall Institute of Medical Research &
Medical Oncologist, Peter MacCallum Cancer Centre, The Royal Women’s Hospital and The Royal Melbourne Hospital
Australian Health Journal Talk
Filmed Online | April 2025
Professor Clare Scott, a pioneering clinician scientist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, also serves as a medical oncologist at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
Her comprehensive training in medical oncology has fuelled her specialisation in gynaecological cancer, combining rigorous research with clinical trials to improve patient outcomes. With over a decade of involvement in ANZGOG, Australia’s foremost gynaecologic cancer research organisation, she is deeply committed to advancing research and saving lives.
ANZGOG’s values—excellence, impact, equity, collaboration, and openness—reflect the organisation’s dedication to transformative cancer research. Its strategic plan is designed around four comprehensive goals, aiming to initiate innovative, practice-changing gynaecological cancer research. This not only expands the reach of impactful studies but also ensures that research directly benefits the community, ultimately improving the lives of countless women affected by these cancers.
Ovarian cancer, a complex and diverse group of diseases, poses significant challenges in diagnosis and treatment. While high-grade serous ovarian cancer is often highlighted, other rare types also demand critical attention. With projections indicating over 1,800 Australian women will be diagnosed by 2025, and a startling survival rate of just under 50%, Professor Scott talks of the need to rally together to confront this pressing public health issue. Tragically, two-thirds of cases are diagnosed at an advanced stage, diminishing survival prospects further. As of now, around 5,300 Australian women live with ovarian cancer, facing ongoing challenges that necessitate urgent action and support.
In this Australian Health Journal Talk, Professor Scott talks in detail about the following –
- The incidence of ovarian cancer in Australian women and mortality statistics around advanced stage diagnosis
- The symptoms and why they get dismissed or misdiagnosed
- The challenges in access to screening, treatment and funding for research
She also delivers a message to the medical community and the Australian Government.
Source: Generative AI on transcript
-
Orthopaedic surgeon driven to understand & manage infection
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
-
Allied Health Leader shares career insights
Mirella Vagnarelli is a distinguished healthcare leader with proven expertise across South Australia and the United Kingdom, where she has successfully led large, multidisciplinary teams. Holding a Master of Business Administration (Health) from Flinders University, she earned Fellowship status with the Australasian College of Health Service Management in 2022. In 2023, Mirella was honoured as a scholarship recipient for the prestigious ‘Women in Leadership’ Program at the Monash Centre for Health Research and Implementation.
